INTC Plunges 35% in the Past Year: Should You Dump the Stock?

Intel's stock has declined 35.1% over the past year, underperforming competitors like NVIDIA, due to financial strain, lagging innovation in AI chips, and challenges in the Chinese market, which accounts for over 29% of Intel's 2024 revenue. Earnings estimates for 2025 and 2026 have been significantly reduced, reflecting a weak outlook, despite Intel's efforts to expand manufacturing capacity and its receipt of $7.86 billion in U.S. government funding under the CHIPS Act.

Analysis

Intel Corporation (INTC) has experienced a significant 35.1% stock price decline over the past year, starkly underperforming the broader semiconductor industry's 12.3% growth and lagging behind key competitors like NVIDIA, which saw a 16.4% increase. This underperformance is attributed to severe financial difficulties, operational challenges, and a notable lag in AI chip innovation where rivals have gained substantial ground with successful products like NVIDIA's H100 and Blackwell GPUs. Intel's financial health is further strained by margin pressures stemming from multiple factors, including the accelerated ramp-up of AI PC production shifting to a higher-cost facility in Ireland, charges associated with non-core businesses and unused capacity, an unfavorable product mix, and aggressive pricing competition. A major concern is Intel's significant exposure to the Chinese market, which accounted for over 29% of its total revenues in 2024; China's directive to replace U.S.-made chips by 2027, coupled with escalating U.S.-China trade tensions and Beijing's push for technological self-sufficiency, poses a substantial risk to Intel's revenue and market share. Reflecting these headwinds, earnings estimates for Intel have been severely revised downwards, with 2025 estimates falling by 40.8% to 29 cents and 2026 estimates declining by 31.2% to 77 cents over the past year, indicating bearish sentiment. While Intel is actively pursuing its IDM 2.0 strategy, investing in expanding manufacturing capacity (bolstered by $7.86 billion in U.S. CHIPS Act funding), and progressing with its 5N4Y program to regain process leadership by 2025, alongside launching new products like the Xeon 6 processors, the prevailing view is that these efforts, while promising for the long term, may be insufficient to rapidly counteract current market challenges, margin erosion, elevated customer inventory levels, and the negative outlook reflected in analyst revisions.

Key Decisions for Investors

• Investors should critically evaluate the substantial execution risks associated with Intel's IDM 2.0 strategy and 5N4Y roadmap, particularly in light of its current lag in AI chip innovation compared to competitors and significantly reduced earnings estimates for 2025 and 2026.
• Closely monitor Intel's ability to address persistent margin pressures, which are impacted by higher production costs, charges from non-core businesses, and intense pricing competition, as improvements here are vital for a financial turnaround.
• Carefully assess the evolving geopolitical landscape, specifically US-China trade relations and China's domestic chip strategy, given China accounted for over 29% of Intel's 2024 revenue and faces increasing restrictions and local competition.
• Existing long-term investors might consider holding their positions with caution, in line with the Zacks Rank #3 (Hold) and the article's suggestion for long-term perspectives, while prospective investors should await more concrete signs of progress in Intel's strategic initiatives and market competitiveness before initiating positions.